Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 440

1.

Dense Annotation of Free-Text Critical Care Discharge Summaries from an Indian Hospital and Associated Performance of a Clinical NLP Annotator.

Ramanan SV, Radhakrishna K, Waghmare A, Raj T, Nathan SP, Sreerama SM, Sampath S.

J Med Syst. 2016 Aug;40(8):187. doi: 10.1007/s10916-016-0541-2. Epub 2016 Jun 24.

PMID:
27342107
2.

Primary Cardiac Sarcoidosis with Syncope and Refractory Atrial Arrhythmia: A Case Report and Review of the Literature.

Thangam M, Nathan S, Kar B, Petrovic M, Patel M, Loyalka P, Buja LM, Gregoric ID.

Tex Heart Inst J. 2016 Jun 1;43(3):236-40. doi: 10.14503/THIJ-14-4792. eCollection 2016 Jun.

3.

Rebuttal From Drs. King and Nathan.

King CS, Nathan SD.

Chest. 2016 May 28. pii: S0012-3692(16)49047-1. doi: 10.1016/j.chest.2016.04.035. [Epub ahead of print] No abstract available.

PMID:
27292048
4.

Point: Should all patients with IPF, even those with more than moderate impairment, be treated with nintedanib or pirfenidone?: Yes.

King CS, Nathan SD.

Chest. 2016 May 28. pii: S0012-3692(16)49046-X. doi: 10.1016/j.chest.2016.04.034. [Epub ahead of print] No abstract available.

PMID:
27292047
5.

Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft.

Grinstein J, Estrada J, Sayer G, Kim GH, Sarswat N, Adatya S, Nathan S, Paul JD, Blair JE, Jeevanandam V, Lang R, Uriel N, Shah AP.

J Card Fail. 2016 Jun 9. pii: S1071-9164(16)30105-1. doi: 10.1016/j.cardfail.2016.04.022. [Epub ahead of print]

PMID:
27291686
6.
7.

Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science.

Hassoun PM, Nathan SD.

Eur Respir J. 2016 Jun;47(6):1615-7. doi: 10.1183/13993003.00395-2016. No abstract available.

PMID:
27246075
8.

PCI in Patients Supported With CF-LVADs: Indications, Safety, and Outcomes.

Anyanwu EC, Ota T, Sayer G, Nathan S, Jeevanandam V, Shah A, Uriel N.

J Invasive Cardiol. 2016 Jun;28(6):238-42.

9.

Examining the pathways for young people with drug and alcohol dependence: a mixed-method design to examine the role of a treatment programme.

Nathan S, Rawstorne P, Hayen A, Bryant J, Baldry E, Ferry M, Williams M, Shanahan M, Jayasinha R.

BMJ Open. 2016 May 25;6(5):e010824. doi: 10.1136/bmjopen-2015-010824.

10.

Benefits of robotic cystectomy with intracorporeal diversion for patients with low cardiorespiratory fitness: A prospective cohort study.

Lamb BW, Tan WS, Eneje P, Bruce D, Jones A, Ahmad I, Sridhar A, Baker H, Briggs TP, Hines JE, Nathan S, Martin D, Stephens RC, Kelly JD.

Urol Oncol. 2016 May 16. pii: S1078-1439(16)30016-3. doi: 10.1016/j.urolonc.2016.04.006. [Epub ahead of print]

PMID:
27197920
11.

A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis.

Anderson A, Shifren A, Nathan SD.

Expert Opin Drug Saf. 2016 Jul;15(7):975-82. doi: 10.1080/14740338.2016.1187129. Epub 2016 May 26.

PMID:
27177012
12.
13.

Transcatheter Therapy for a Large Mobile Right Atrial Thrombus and Massive Pulmonary Embolism.

Narang A, Mediratta A, Estrada JR, Rosenberg J, DeCara JM, Howell MD, Lang RM, Paul JD, Nathan S, Shah AP, Blair JE.

J Invasive Cardiol. 2016 May;28(5):E49-51.

14.

Cryptocaryon irritans recombinant proteins as potential antigens for sero-surveillance of cryptocaryonosis.

Lokanathan Y, Mohd-Adnan A, Kua BC, Nathan S.

J Fish Dis. 2016 Apr 18. doi: 10.1111/jfd.12474. [Epub ahead of print]

PMID:
27086498
15.

Antacid therapy and idiopathic pulmonary fibrosis: cause for heartburn?

Nathan SD.

Lancet Respir Med. 2016 May;4(5):340-1. doi: 10.1016/S2213-2600(16)00102-8. Epub 2016 Mar 31. No abstract available.

PMID:
27050873
16.

Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy.

Kong C, Neoh HM, Nathan S.

Toxins (Basel). 2016 Mar 15;8(3). pii: E72. doi: 10.3390/toxins8030072. Review.

17.

Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.

Fenske TS, Ahn KW, Graff TM, DiGilio A, Bashir Q, Kamble RT, Ayala E, Bacher U, Brammer JE, Cairo M, Chen A, Chen YB, Chhabra S, D'Souza A, Farooq U, Freytes C, Ganguly S, Hertzberg M, Inwards D, Jaglowski S, Kharfan-Dabaja MA, Lazarus HM, Nathan S, Pawarode A, Perales MA, Reddy N, Seo S, Sureda A, Smith SM, Hamadani M.

Br J Haematol. 2016 Mar 15. doi: 10.1111/bjh.14046. [Epub ahead of print]

PMID:
26989808
18.

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.

Nathan SD, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Glasscock KF, King TE Jr, Lancaster L, Lederer DJ, Lin Z, Pereira CA, Swigris JJ, Valeyre D, Noble PW, Wells AU.

Thorax. 2016 May;71(5):429-35. doi: 10.1136/thoraxjnl-2015-207011. Epub 2016 Mar 11.

19.

Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomes.

Tan WS, Sridhar A, Ellis G, Lamb B, Goldstraw M, Nathan S, Hines J, Cathcart P, Briggs T, Kelly J.

Urol Oncol. 2016 Jun;34(6):257.e1-9. doi: 10.1016/j.urolonc.2016.02.010. Epub 2016 Mar 8.

PMID:
26968561
20.

Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry Cohort.

Dickinson L, Arya M, Afzal N, Cathcart P, Charman SC, Cornaby A, Hindley RG, Lewi H, McCartan N, Moore CM, Nathan S, Ogden C, Persad R, van der Meulen J, Weir S, Emberton M, Ahmed HU.

Eur Urol. 2016 Mar 4. pii: S0302-2838(16)00244-X. doi: 10.1016/j.eururo.2016.02.054. [Epub ahead of print]

PMID:
26951947
Items per page

Supplemental Content

Loading ...
Write to the Help Desk